Ken Mandell

Dr. Mandell is a Harvard-trained ophthalmologist with 15+ years ophthalmic product development experience. He has more than 10 granted U.S. patents and is co-inventor of TYRVAYA® (Oyster Point), FDA-approved treatment for dry eye disease. Dr. Mandell has personally contributed to more than a dozen Investigational New Drug (IND) applications and overseen the conduct of numerous Phase 1-3 clinical trials in the field of ophthalmology. He is Founder of the MIT-spinoff LayerBio, Inc. and currently serves as strategic advisor to Aramis Biosciences, a Harvard spin-off developing novel therapies for eye disease.